Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents.
D000818:Animals; D001779:Blood Coagulation Factors / Q000378:metabolism*; D001792:Blood Platelets; D003994:Bucladesine / Q000494:pharmacology; D002417:Cattle; D003078:Colchicine / Q000494:pharmacology; D000242:Cyclic AMP / Q000097:blood*; D003571:Cytochalasin B / Q000494:pharmacology; D003599:Cytoskeleton; D011464:Epoprostenol / Q000494:pharmacology; D006583:Hexadimethrine Bromide / Q000494:pharmacology; D010974:Platelet Aggregation; D011458:Prostaglandins E / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology; D014841:von Willebrand Factor / Q000378:metabolism*
D001779:Blood Coagulation Factors; D011458:Prostaglandins E; D014841:von Willebrand Factor; D003571:Cytochalasin B; D006583:Hexadimethrine Bromide; D014747:Vinblastine; D003994:Bucladesine; D011464:Epoprostenol; D000242:Cyclic AMP; D003078:Colchicine